Health Canada
- Status: approved
🇨🇦 Aromatase inhibitor and GnRH analog in Canada
Aromatase inhibitor and GnRH analog (Aromatase inhibitor and GnRH analog) regulatory status in Canada.
Marketing authorisation
Aromatase inhibitor and GnRH analog in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Aromatase inhibitor and GnRH analog approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Aromatase inhibitor and GnRH analog in Canada?
Centre for Endocrinology and Reproductive Medicine, Italy is the originator. The local marketing authorisation holder may differ — check the official source linked above.